Transaction · 0001193125-26-424421

Evans John M.

Evans John M., CEO, reported an open-market or private sale at Beam Therapeutics Inc. involving 25000.000000 shares for an estimated $599595.00. Reported holdings after the transaction were 1047205.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SCEO
BEAMBeam Therapeutics Inc.
Trade date
Oct 16, 2026
Filing date
Oct 17, 2026
View on SEC Insider profile
Estimated value-$599kShares × reported price
Shares traded25.0k$23.98 per share
Holdings after1.04MDirect
% of reported position traded2.33%This security and ownership context
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 1,072,205 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

BEAM price since this filing

Daily closing prices, with the filing date and available return windows
BEAM · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +25.5%1w ago +9.5%1d ago +5.4%
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001193125-26-424421
Common Stock
Transaction date
Oct 16, 2026
Filed Oct 17, 2026, 12:09 AM · 1d delay
Shares
25,000 sh
$23.98 per share
Estimated value
-$599k
Computed from shares × price
Holdings after
1,047,205 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership Repeat Seller 10b5-1 Detected
Filing-only score

0 points

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 1

    Filing reported within two business days of the transaction.
  • tenb5_1_detected-10 points

    is_10b5_1 = true

    Stored filing content includes detected 10b5-1 language.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

CEO

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The stock options were exercised and the shares of common stock were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 16, 2026.

  2. F2

    The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $23.23 to $23.84, inclusive. The Reporting Person undertakes to provide to Beam…

  3. F3

    The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $23.66 to $24.56, inclusive. The Reporting Person undertakes to provide to BEAM…

  4. F4

    On July 13, 2018, the Reporting Person was granted an option to purchase 539,645 shares of common stock, which vested as to 25% of the underlying shares on January 8, 2019 and in 36 equal monthly inst…

Original filing · 0001193125-26-424421
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

BEAM